Journal
ELIFE
Volume 5, Issue -, Pages -Publisher
eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.16090
Keywords
-
Categories
Funding
- Medical Research Council
- Department for International Development
- Innovative Vector Control Consortium
- Wellcome Trust ISSF Grant
- European Research Council [265660]
- MRC [MR/K010174/1, G1002284] Funding Source: UKRI
- Medical Research Council [MR/K010174/1B, MR/K010174/1, G1002284] Funding Source: researchfish
Ask authors/readers for more resources
Long lasting pyrethroid treated bednets are the most important tool for preventing malaria. Pyrethroid resistant Anopheline mosquitoes are now ubiquitous in Africa, though the public health impact remains unclear, impeding the deployment of more expensive nets. Meta-analyses of bioassay studies and experimental hut trials are used to characterise how pyrethroid resistance changes the efficacy of standard bednets, and those containing the synergist piperonyl butoxide (PBO), and assess its impact on malaria control. New bednets provide substantial personal protection until high levels of resistance, though protection may wane faster against more resistant mosquito populations as nets age. Transmission dynamics models indicate that even low levels of resistance would increase the incidence of malaria due to reduced mosquito mortality and lower overall community protection over the life-time of the net. Switching to PBO bednets could avert up to 0.5 clinical cases per person per year in some resistance scenarios.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available